1. Appetite-suppressant drugs and the risk of primary pulmonary hypertension;Abenhaim;N Engl J Med,1996
2. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation;Baseman;Neurology,2004
3. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France;Begaud;Thérapie,1985
4. Valvulopathie réversible et traitement par pergolide;Calomne;Rev Neurol (Paris),2004
5. Pergolide associated valvulopathies: 11 cases observed in Belgium. Program and abstracts of the 57th Annual Meeting of the American Academy of Neurology; April 9-16; Miami Beach, Florida;Evrard;Poster Presentation P02,2005